Legal Representation
Attorney
Helena H. Kwon
USPTO Deadlines
Next Deadline
384 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2006-08-01)
Due Date
August 01, 2026
Grace Period Ends
February 01, 2027
Application History
50 events| Date | Code | Type | Description |
|---|---|---|---|
| Oct 6, 2016 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Oct 6, 2016 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| Oct 6, 2016 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
| Oct 6, 2016 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
| Jul 24, 2016 | E89R | I | TEAS SECTION 8 & 9 RECEIVED |
| Aug 1, 2015 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| Dec 16, 2013 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Dec 16, 2013 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Dec 13, 2013 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Dec 13, 2013 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Mar 26, 2013 | 8.PR | O | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED |
| Mar 26, 2013 | NAS8 | O | NOTICE OF ACCEPTANCE OF SEC. 8 - MAILED |
| Mar 4, 2013 | EROP | I | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| Mar 4, 2013 | EROP | I | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| Mar 4, 2013 | EROP | I | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| Feb 13, 2013 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Sep 5, 2012 | PRA8 | O | POST REGISTRATION ACTION MAILED - SEC. 8 |
| Aug 6, 2012 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Jul 30, 2012 | ES8R | I | TEAS SECTION 8 RECEIVED |
| Jul 30, 2012 | 8.AF | I | REGISTERED - SEC. 8 (6-YR) FILED |
| Mar 29, 2007 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Mar 29, 2007 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Aug 1, 2006 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| May 9, 2006 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Apr 19, 2006 | NPUB | O | NOTICE OF PUBLICATION |
| Mar 13, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Feb 28, 2006 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Feb 27, 2006 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Feb 24, 2006 | ALIE | A | ASSIGNED TO LIE |
| Feb 23, 2006 | DOCK | D | ASSIGNED TO EXAMINER |
| Feb 23, 2006 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Feb 23, 2006 | DOCK | D | ASSIGNED TO EXAMINER |
| Feb 23, 2006 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Feb 23, 2006 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Feb 21, 2006 | OTHE | I | CASE RETURNED TO EXAMINATION |
| Feb 14, 2006 | DOCK | D | ASSIGNED TO EXAMINER |
| Feb 5, 2006 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Jan 9, 2006 | I | PAPER RECEIVED | |
| Jan 6, 2006 | FAXX | I | FAX RECEIVED |
| Jan 5, 2006 | EXT3 | S | SOU EXTENSION 3 FILED |
| Aug 4, 2005 | PCGR | O | PETITION TO DIRECTOR GRANTED |
| Jul 13, 2005 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Jul 5, 2005 | I | PAPER RECEIVED | |
| Jul 5, 2005 | EXT2 | S | SOU EXTENSION 2 FILED |
| Jun 23, 2005 | I | PAPER RECEIVED | |
| Jun 23, 2005 | PCRC | I | PETITION TO DIRECTOR RECEIVED |
| Jun 23, 2005 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED |
| Jan 6, 2005 | I | PAPER RECEIVED | |
| Jan 6, 2005 | EXT1 | S | SOU EXTENSION 1 FILED |
| Jan 6, 2005 | EX1G | S | SOU EXTENSION 1 GRANTED |
Detailed Classifications
Class 005
[ Agents affecting central nervous system, namely, pharmaceutical preparations for the treatment of central nervous system disorders; agents affecting peripheral nervous system, namely, pharmaceutical preparations for the treatment of peripheral nervous system disorders; agents affecting digestive organs, namely, pharmaceutical preparations for the treatment of digestive organs; agents affecting circulatory organs, namely, pharmaceutical preparations for the treatment of circulatory organs; agents for uro-genital organs, namely, pharmaceutical preparations for the treatment of uro-genital organs; pharmaceutical nutrients and tonics preparation for the treatment of human medical disorders, dysfunctions and diseases; pharmaceuticals, namely, tumor suppressing agents; crude pharmaceutical drug preparations for digestive organs; ] ginseng capsules for medical use; [ agents for reducing blood sugar, namely, pharmaceutical preparations for the treatment of reducing blood sugar; ] dietary supplements containing chitosan, ginseng and chlorella and food supplements containing chitosan, ginseng and chlorella
First Use Anywhere:
0
First Use in Commerce:
0
Class 029
Processed ginsengs for use as a vegetable; processed red ginseng for use as a vegetable; [ kimchi, namely, whole radish and cabbage kimchi; frozen, prepared or packaged fish meal for human consumption; milk; yogurt; sweet bean jelly ]
First Use Anywhere:
0
First Use in Commerce:
0
Class 030
Goods for management of health, namely, processed red ginseng used as an herb, spice or flavoring ginseng tea; red ginseng tea; [ green tea; candy; confectionery, namely, confectionery chips for baking and peanut butter confectionery chips; cake; chewing gums; chocolate; honey; red pepper paste ]
First Use Anywhere:
0
First Use in Commerce:
0
Class 031
[ Natural living plants and flowers, namely, ginsengs; raw, fresh and unprocessed mushrooms, namely, pine mushrooms, shiitake mushrooms and truffles ]
First Use Anywhere:
0
First Use in Commerce:
0
Class 032
Ginseng juice; red ginseng juice; non-alcoholic ginseng extracts used in the preparation of beverages; ginseng powder used in the preparation of soft drinks; red ginseng powder used in the preparation of soft drinks; ginseng nectar for non-alcoholic beverages; red ginseng nectar for non-alcoholic beverages; [ vegetable juice beverages; aerated fruit juice beverages; beer; spring water ]
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
029
030
031
032
USPTO Documents
Loading USPTO documents...